Beta Bionics (BBNX) Assets (2023 - 2026)

Beta Bionics has disclosed Assets across 4 years of filings, most recently posting $292.4 million for Q2 2026.

• In Q2 2026, Assets fell 11.39% year-over-year to $292.4 million; the TTM figure through Jun 2026 stood at $292.4 million (down 11.39% YoY), while the FY2025 annual figure was $328.7 million, up 119.68% from the prior year.
• Assets came in at $292.4 million for Q2 2026 at Beta Bionics, down from $304.4 million in the prior quarter.
• In the past five years, Assets ranged from a high of $338.0 million in Q1 2025 to a low of $110.0 million in Q4 2023.
• Average Assets over 4 years is $272.9 million, with a median of $316.6 million recorded in 2025.
• Year-over-year, Assets surged 119.68% in 2025 and dropped 11.39% in 2026.
• Over 4 years, Assets stood at $110.0 million in 2023, then soared by 35.99% to $149.6 million in 2024, then surged by 119.68% to $328.7 million in 2025, then declined by 11.06% to $292.4 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $292.4 million in Q2 2026, $304.4 million in Q1 2026, and $328.7 million in Q4 2025.